ESAB Corporation Announces Fourth Quarter 2022 Results

(marketscreener.com) Achieved $0.97 diluted EPS from continuing operations, and $1.05 of core adjusted diluted EPSIncreased sales 6% with core organic growth of 11%Reported net income from continuing operations attributable to ESAB of $59 million and core adjusted EBITDA of $107 million, up 10% versus prior year fourth quarterCompleted Swift-Cut and Therapy...https://www.marketscreener.com/quote/stock/ESAB-CORPORATION-135355428/news/ESAB-Corporation-Announces-Fourth-Quarter-2022-Results-43179585/?utm_medium=RSS&utm_content=20230307